Combo Product Office To Tackle Intercenter Agreements, “Chemical Action”
This article was originally published in The Gray Sheet
Executive Summary
FDA's final rule defining primary mode of action will be released within the next six months, Office of Combination Products Director Mark Kramer projected Jan. 11-12